MDGL plans Rule 144 sale of common shares

MDGL filed a Rule 144 notice covering the planned sale of 18650 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ.

Rhea-AI Filing Summary

MDGL filed a Rule 144 notice covering the planned sale of 18650 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ.

These shares were acquired on 01/09/2026 by exercising stock options for cash and have an aggregate market value of 10373503.00. The issuer reports 22711420 shares outstanding. In the past three months, 10b5-1 sales disclosed include 18650 shares for Rebecca A Taub with gross proceeds of 10297573.26 and 24800 shares for Paul A Friedman with gross proceeds of 13694158.24.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MDGL Rule 144 filing disclose?

The filing discloses a planned sale of 18650 shares of MDGL common stock under Rule 144 through Morgan Stanley Smith Barney LLC on NASDAQ.

How many MDGL shares are planned to be sold under this Rule 144 notice?

The notice covers the planned sale of 18650 shares of MDGL common stock.

How were the MDGL shares being sold under Rule 144 acquired?

The 18650 MDGL common shares were acquired on 01/09/2026 through the exercise of stock options, with the purchase price paid in cash.

What prior 10b5-1 sales related to MDGL are disclosed in the past three months?

Disclosed 10b5-1 sales include 18650 shares for Rebecca A Taub with gross proceeds of 10297573.26 and 24800 shares for Paul A Friedman with gross proceeds of 13694158.24, both on 12/10/2025.

How many MDGL shares are reported as outstanding in this filing?

The filing reports 22711420 shares of MDGL common stock outstanding.

Which broker and exchange are involved in the MDGL Rule 144 sale?

The planned sale will be executed through Morgan Stanley Smith Barney LLC on the NASDAQ exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/09/2026 - 04:30 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001423898
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MADRIGAL PHARMACEUTICALS, INC.
SEC File Number	001-33277
Address of Issuer	Four Tower Bridge West Conshohocken PENNSYLVANIA 19428
Phone	2678242827
Name of Person for Whose Account the Securities are To Be Sold	REBECCA A TAUB
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	18650	10373503.00	22711420	01/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/09/2026	Exercise of Stock Options	Issuer			18650	01/09/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for REBECCA A TAUB Four Tower Bridge West Conshohocken PA 19428	Common	12/10/2025	18650	10297573.26
10b5-1 Sales for PAUL A FRIEDMAN Four Tower Bridge West Conshohocken PA 19428	Common	12/10/2025	24800	13694158.24

144: Remarks and Signature

Remarks	The reported sales occur automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 09/10/2025.
Date of Notice	01/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Rebecca A Taub
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)